Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationMHRA adds GPvP Inspection Metrics report for April 2020 to March 2021
In October 2020, the MHRA launched a 6-week consultation with stakeholders on the MHRA draft guidance on randomised controlled trials generating real-world evidence to support regulatory decisions. Following the consultation and an analysis of the responses received, the MHRA has published two guidance documents.
MHRA's new guidance on using real-world data to support clinical trials could get medicines to patients sooner
EMA have just released their CTIS Highlights newsletter
Global reflections on international inspection transformation: ICMRA remote inspections
The European Commission (EC) has published a guideline on Good Lay Summary Practice"(GLSP). The guideline was adopted by the Clinical Trials Expert Group (CTEG) of the EU Commission, which is composed of representatives of ethics committees and national competent authorities.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
Additional guidance on requesting a UK PSMF number was added on 30th November 2021.
EMA - Publication of Article on Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021